Drug name - Testosterone Cypionate
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US11311554 | SLAYBACK PHARMA LLC | Pharmaceutical compositions of testosterone |
Mar, 2039
(16 years from now) | |
Drugs and Companies using TESTOSTERONE CYPIONATE ingredient
Market Authorisation Date: 02 June, 2022
Treatment: NA
Dosage: SOLUTION;INTRAMUSCULAR
More Information on Dosage
| Strength | Dosage | Availability |
|---|---|---|
| 200MG/ML (200MG/ML) | SOLUTION;INTRAMUSCULAR | Discontinued |
availability in other generic markets.
Click on the highlighted region to filter.